載入...
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Peptide modified nanoparticles have been engineered as novel strategies to improve esophageal adenocarcinoma (EAC) therapy. This study aimed to develop a trastuzumab (TAB) modified system for the delivery of cisplati...
Na minha lista:
| 發表在: | Drug Deliv |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598994/ https://ncbi.nlm.nih.gov/pubmed/33118428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1837294 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|